Results
1 -
10 of
91Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo, Psychopharmacology In vivo characteristics of dopamine D2 receptor occupancy by amisulpride in schizophrenia, Psychopharmacology Neuroendocrine profile of SDZ HDC-912 and OPC-4392, two new atypical antipsychotic drugs, in schizophrenic patients, Psychopharmacology The dopaminergic reward system underpins gender differences in social preferences, Nature Human Behaviour Amisulpride in the prevention of nausea and vomiting induced by cisplatin-based chemotherapy: a dose-escalation study, Supportive Care in Cancer Effects of (???)-OSU6162 and ACR16 on motor activity in rats, indicating a unique mechanism of dopaminergic stabilization, Journal of Neural Transmission ??-Lipoic Acid Interaction with Dopamine D2 Receptor-Dependent Activation of the Akt/GSK-3?? Signaling Pathway Induced by Antipsychotics: Potential Relevance for the Treatment of Schizophrenia, Journal of Molecular Neuroscience Implication of the ERK/MAPK Pathway in Antipsychotics-induced Dopamine D2 Receptor Upregulation and in the Preventive Effects of (??)-??-lipoic acid in SH-SY5Y Neuroblastoma Cells, Journal of Molecular Neuroscience Non-uniform blockade of intrastriatal D2/D3 receptors by risperidone and amisulpride, Psychopharmacology Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: I. neurochemical characterisation of RG-15, Naunyn-Schmiedeberg's Archives of Pharmacology